• Skip to main content
  • Skip to primary sidebar

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

Portfolio

/ November 15, 2016

TPC Group

TPC Group

TPC Group is a leading producer of value-added products derived from niche petrochemical raw materials such as C4 hydrocarbons. The Company processes C4 hydrocarbons into butadiene, butene-1, isobutylene and differentiated isobutylene derivatives for use in performance and specialty products in the synthetic rubber, fuels, lubricants, plastics and nylon industries. Headquartered in Houston, Texas, TPC Group operates one manufacturing facility and two terminals in the United States and employs over 450 people.

SK Capital Partners took TPC Group private in partnership with First Reserve Corporation in December 2012.

For more information, please visit: www.tpcgrp.com

Primary Sidebar

Related News

  • TPC Group Announces New Chief Executive Officer

    January 7, 2016
  • SK Capital Partners Completes Acquisition Of TPC Group Inc.

    December 20, 2012
  • TPC Group Inc. Enters into Merger Agreement with First Reserve Corporation and SK Capital Partners

    August 27, 2012

SK Capital Portfolio Companies

  • Luxium Solutions
  • VanDeMark Chemical, Inc
  • Valtris Specialty Chemicals
  • Florachem
  • Heubach
  • Seqens
  • Deltech LLC
  • Canlak
  • IPACKCHEM
  • Woodstock Sterile Solutions
  • Lacerta Group
  • Venator
  • Tilley Distribution
  • NuCera Solutions
  • Techmer PM
  • GEON
  • SI Group
  • Perimeter Solutions
  • Wavelength
  • Foremark
  • Tri-Tex
  • Niacet
  • Noramco
  • Extractas Bioscience
  • Purisys
  • Archroma
  • Addivant
  • TPC Group
  • Ascend
  • IBA Molecular
  • Calabrian Corporation
  • Halo Pharmaceutical
  • AEB Group

To request for a copy of our ESG report, please click here.

© 2023 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login